AT EVERY TURN
Clinical endpoint data collection, predictive analytics, and real world evidence – draw on our science, technological, global experience and credibility, learned over 15k trials, to power your clinical development with certainty, quality and speed
moving ahead requires a sure path forward
Every detail matters. We spot risks before they become problems and help you avoid costly delays through our latest solution Trial Oversight.
MINIMIZE RISK AND UNCERTAINTY
We deliver the flexibility and adaptability you need to overcome challenges for faster speed to market. Here’s how:
NEWS & EVENTS
July 18, 2019
FDA Guidance For ABPM: Capture the Data That Matters
To learn more about this FDA guidance, ABPM, and blood pressure monitoring best practices, please join us on July 18.
June 24, 2019
ERT Participates in Groundbreaking, Digital Technology Research
MOBILISE-D to revolutionize the assessment and treatment of impaired mobility for improved healthcare
July 10, 2019
Patient-Reported Outcome (PRO) Data in Oncology Trials – Part 1: Regulations
In this first of a 2-part series on the importance of PRO data in oncology drug development, we review the latest regulatory guidances recommending the use of PROs in oncology trials.